SmarTrend's candlestick scanner has spotted a possible bullish inside day candle pattern in Nxstage Medical (NASDAQ:NXTM) based on the price action in the company's shares. Yesterday's price range of $28.27 and $28.66 is within the prior day's high and low of the day. This trading action often signifies indecision by bulls and bears to drive prices higher or lower and often implies a possible change in trend. Traders and investors interested in shares of Nxstage Medical may want to consider an appropriate entry level in the event a reversal to the upside transpires. It is important to look for confirmation.

NxStage Medical, Inc. is medical device company. The Company develops, manufactures, and markets systems for the treatment of end-stage renal disease and acute kidney failure. NxStage Medical conducts business worldwide.

Nxstage Medical has overhead space with shares priced $28.34, or 5.5% below the average consensus analyst price target of $30.00. The stock should discover initial support at its 50-day moving average (MA) of $28.31 and subsequent support at its 200-day MA of $27.20.

Over the past year, Nxstage Medical has traded in a range of $22.70 to $29.26 and closed yesterday at $28.34, 25% above that low. The 200-day and 50-day moving averages have moved 0.26% higher and 0.07% higher over the past week, respectively.

SmarTrend recommended that subscribers consider buying shares of Nxstage Medical on June 28th, 2017 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $25.01. Since that recommendation, shares of Nxstage Medical have risen 14.6%. We continue to monitor NXTM for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.